Tango Therapeutics (TNGX) Short-term Investments (2020 - 2026)

Tango Therapeutics' Short-term Investments history runs 7 years deep, the most recent figure standing at $222.0 million for Q1 2026.

• In Q1 2026, Short-term Investments rose 40.25% year-over-year to $222.0 million; the TTM figure through Mar 2026 stood at $222.0 million (up 40.25% YoY), while the FY2025 annual figure was $428000.0, down 99.77% from the prior year.
• Short-term Investments was $222.0 million for Q1 2026 at Tango Therapeutics, up from $428000.0 in the prior quarter.
• In the past five years, Short-term Investments ranged from a high of $350.0 million in Q1 2022 to a low of $428000.0 in Q4 2025.
• Historically, Short-term Investments has averaged $131.1 million across 5 years, with a median of $141.5 million in 2025.
• The sharpest annual moves came in 2022 and 2024: Short-term Investments slumped 99.81% in 2022, then jumped 31505.72% in 2024.
• A 5-year view of Short-term Investments shows it stood at $567000.0 in 2022, then jumped by 58.73% to $900000.0 in 2023, then jumped by 20831.89% to $188.4 million in 2024, then tumbled by 99.77% to $428000.0 in 2025, then jumped by 51771.73% to $222.0 million in 2026.
• The last three Short-term Investments figures came in at $222.0 million (Q1 2026), $428000.0 (Q4 2025), and $94.5 million (Q3 2025), per Business Quant data.